Literature DB >> 31061090

PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.

Ye Zhou1, Joshua R Miles2,3, Hagai Tavori2,3, Min Lin1, Habibeh Khoshbouei1, David R Borchelt1, Hannah Bazick1, Gary E Landreth4, Sooyeon Lee1, Sergio Fazio2,3, Lucia Notterpek5,6.   

Abstract

The absence of functional peripheral myelin protein 22 (PMP22) is associated with shortened lifespan in rodents and severe peripheral nerve myelin abnormalities in several species including humans. Schwann cells and nerves from PMP22 knock-out (KO) mice show deranged cholesterol distribution and aberrant lipid raft morphology, supporting an unrecognized role for PMP22 in cellular lipid metabolism. To examine the mechanisms underlying these abnormalities, we studied Schwann cells and nerves from male and female PMP22 KO mice. Whole-cell current-clamp recordings in cultured Schwann cells revealed increased membrane capacitance and decreased membrane resistance in the absence of PMP22, which was consistent with a reduction in membrane cholesterol. Nerves from PMP22-deficient mice contained abnormal lipid droplets, with both mRNA and protein levels of apolipoprotein E (apoE) and ATP-binding cassette transporter A1 (ABCA1) being highly upregulated. Despite the upregulation of ABCA1 and apoE, the absence of PMP22 resulted in reduced localization of the transporter to the cell membrane and diminished secretion of apoE. The absence of PMP22 also impaired ABCA1-mediated cholesterol efflux capacity. In nerves from ABCA1 KO mice, the expression of PMP22 was significantly elevated and the subcellular processing of the overproduced protein was aberrant. In wild-type samples, double immunolabeling identified overlapping distribution of PMP22 and ABCA1 at the Schwann cell plasma membrane and the two proteins were coimmunoprecipitated from Schwann cell and nerve lysates. Together, these results reveal a novel role for PMP22 in regulating lipid metabolism and cholesterol trafficking through functional interaction with the cholesterol efflux regulatory protein ABCA1.SIGNIFICANCE STATEMENT Understanding the subcellular events that underlie abnormal myelin formation in hereditary neuropathies is critical for advancing therapy development. Peripheral myelin protein 22 (PMP22) is an essential peripheral myelin protein because its genetic abnormalities account for ∼80% of hereditary neuropathies. Here, we demonstrate that in the absence of PMP22, the cellular and electrophysiological properties of the Schwann cells' plasma membrane are altered and cholesterol trafficking and lipid homeostasis are perturbed. The molecular mechanisms for these abnormalities involve a functional interplay among PMP22, cholesterol, apolipoprotein E, and the major cholesterol-efflux transporter protein ATP-binding cassette transporter A1 (ABCA1). These findings establish a critical role for PMP22 in the maintenance of cholesterol homeostasis in Schwann cells.
Copyright © 2019 the authors.

Entities:  

Keywords:  ATP-binding cassette transporter 1; Schwann cell; apoE; cholesterol efflux; hereditary neuropathy; peripheral myelin protein 22

Mesh:

Substances:

Year:  2019        PMID: 31061090      PMCID: PMC6607759          DOI: 10.1523/JNEUROSCI.2942-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  92 in total

1.  ABC1: connecting yellow tonsils, neuropathy, and very low HDL.

Authors:  H H Hobbs; D J Rader
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease.

Authors:  Y Parman; V Planté-Bordeneuve; A Guiochon-Mantel; M Eraksoy; G Said
Journal:  Ann Neurol       Date:  1999-04       Impact factor: 10.422

5.  Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin.

Authors:  D D'Urso; P Ehrhardt; H W Müller
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

Review 6.  Cholesterol and other membrane active sterols: from membrane evolution to "rafts".

Authors:  Y Barenholz
Journal:  Prog Lipid Res       Date:  2002-01       Impact factor: 16.195

7.  Dejerine-sottas disease with a novel de novo dominant mutation, Ser 149 Arg, of the peripheral myelin protein 22.

Authors:  A Ohnishi; T Yamamoto; K Izawa; S Yamamori; K Takahashi; H Mega; K Jinnai
Journal:  Acta Neuropathol       Date:  2000-03       Impact factor: 17.088

8.  cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.

Authors:  Bassam Haidar; Maxime Denis; Larbi Krimbou; Michel Marcil; Jacques Genest
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

9.  PMP22 accumulation in aggresomes: implications for CMT1A pathology.

Authors:  L Notterpek; M C Ryan; A R Tobler; E M Shooter
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

10.  Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.

Authors:  A Venkateswaran; B A Laffitte; S B Joseph; P A Mak; D C Wilpitz; P A Edwards; P Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

View more
  11 in total

1.  Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.

Authors:  Justin T Marinko; Bruce D Carter; Charles R Sanders
Journal:  J Biol Chem       Date:  2020-07-09       Impact factor: 5.157

2.  A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.

Authors:  Nina Ha; Young Il Choi; Namhee Jung; Ju Young Song; Dae Kwon Bae; Min Cheol Kim; Yong Jae Lee; Hyeseung Song; Geon Kwak; Soyeon Jeong; Saeyoung Park; Soo Hyun Nam; Sung-Chul Jung; Byung-Ok Choi
Journal:  Br J Pharmacol       Date:  2020-09-27       Impact factor: 8.739

3.  Dysregulated miR-29a-3p/PMP22 Modulates Schwann Cell Proliferation and Migration During Peripheral Nerve Regeneration.

Authors:  Yinying Shen; Zhangchun Cheng; Sailing Chen; Yunsong Zhang; Qi Chen; Sheng Yi
Journal:  Mol Neurobiol       Date:  2021-11-27       Impact factor: 5.590

Review 4.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

5.  Ion mobility-mass spectrometry reveals the role of peripheral myelin protein dimers in peripheral neuropathy.

Authors:  Sarah M Fantin; Kristine F Parson; Pramod Yadav; Brock Juliano; Geoffrey C Li; Charles R Sanders; Melanie D Ohi; Brandon T Ruotolo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

6.  Glycosylation Limits Forward Trafficking of the Tetraspan Membrane Protein PMP22.

Authors:  Justin T Marinko; Madison T Wright; Jonathan P Schlebach; Katherine R Clowes; Darren R Heintzman; Lars Plate; Charles R Sanders
Journal:  J Biol Chem       Date:  2021-04-29       Impact factor: 5.157

7.  Key role for lipids in cognitive symptoms of schizophrenia.

Authors:  Dorien A Maas; Marijn B Martens; Nikos Priovoulos; Wieteke A Zuure; Judith R Homberg; Brahim Nait-Oumesmar; Gerard J M Martens
Journal:  Transl Psychiatry       Date:  2020-11-12       Impact factor: 6.222

8.  Central Alteration in Peripheral Neuropathy of Trembler-J Mice: Hippocampal pmp22 Expression and Behavioral Profile in Anxiety Tests.

Authors:  Juan Pablo Damián; Lucia Vázquez Alberdi; Lucía Canclini; Gonzalo Rosso; Silvia Olivera Bravo; Mariana Martínez; Natalia Uriarte; Paul Ruiz; Miguel Calero; María Vittoria Di Tomaso; Alejandra Kun
Journal:  Biomolecules       Date:  2021-04-19

9.  Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.

Authors:  Harrison Pantera; Bo Hu; Daniel Moiseev; Chris Dunham; Jibraan Rashid; John J Moran; Kathleen Krentz; C Dustin Rubinstein; Seongsik Won; Jun Li; John Svaren
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

10.  Peripheral myelin protein 22 preferentially partitions into ordered phase membrane domains.

Authors:  Justin T Marinko; Anne K Kenworthy; Charles R Sanders
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.